nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—ABCB1—hematologic cancer	0.0977	1	CbGaD
Propafenone—CYP1A2—Anagrelide—hematologic cancer	0.0269	0.0475	CbGbCtD
Propafenone—CYP2C9—Bexarotene—hematologic cancer	0.0168	0.0297	CbGbCtD
Propafenone—ABCB1—Lenalidomide—hematologic cancer	0.0163	0.0288	CbGbCtD
Propafenone—CYP2C8—Bortezomib—hematologic cancer	0.0148	0.0261	CbGbCtD
Propafenone—CYP2D6—Lomustine—hematologic cancer	0.0143	0.0252	CbGbCtD
Propafenone—CYP1A2—Carmustine—hematologic cancer	0.0142	0.0249	CbGbCtD
Propafenone—CYP2C9—Idarubicin—hematologic cancer	0.0139	0.0246	CbGbCtD
Propafenone—CYP2D6—Idarubicin—hematologic cancer	0.0128	0.0225	CbGbCtD
Propafenone—CYP1A2—Methoxsalen—hematologic cancer	0.012	0.0212	CbGbCtD
Propafenone—CYP1A2—Bortezomib—hematologic cancer	0.0114	0.0202	CbGbCtD
Propafenone—CYP2C8—Ifosfamide—hematologic cancer	0.0113	0.02	CbGbCtD
Propafenone—CYP1A2—Daunorubicin—hematologic cancer	0.0109	0.0193	CbGbCtD
Propafenone—CYP2D6—Hydroxyurea—hematologic cancer	0.0108	0.0191	CbGbCtD
Propafenone—CYP1A2—Alitretinoin—hematologic cancer	0.0107	0.0189	CbGbCtD
Propafenone—CYP2C9—Bortezomib—hematologic cancer	0.0103	0.0182	CbGbCtD
Propafenone—CYP1A2—Thalidomide—hematologic cancer	0.00997	0.0176	CbGbCtD
Propafenone—CYP2C8—Nilotinib—hematologic cancer	0.00985	0.0174	CbGbCtD
Propafenone—CYP3A4—Bexarotene—hematologic cancer	0.00978	0.0172	CbGbCtD
Propafenone—ABCB1—Daunorubicin—hematologic cancer	0.00957	0.0169	CbGbCtD
Propafenone—CYP2D6—Bortezomib—hematologic cancer	0.00943	0.0166	CbGbCtD
Propafenone—ABCB1—Alitretinoin—hematologic cancer	0.00938	0.0165	CbGbCtD
Propafenone—CYP3A4—Lomustine—hematologic cancer	0.0091	0.016	CbGbCtD
Propafenone—CYP3A4—Busulfan—hematologic cancer	0.0091	0.016	CbGbCtD
Propafenone—CYP2C9—Thalidomide—hematologic cancer	0.00899	0.0158	CbGbCtD
Propafenone—CYP1A2—Dacarbazine—hematologic cancer	0.00858	0.0151	CbGbCtD
Propafenone—CYP2C9—Teniposide—hematologic cancer	0.00857	0.0151	CbGbCtD
Propafenone—CYP1A2—Imatinib—hematologic cancer	0.00839	0.0148	CbGbCtD
Propafenone—CYP3A4—Thiotepa—hematologic cancer	0.00811	0.0143	CbGbCtD
Propafenone—CYP2C9—Ifosfamide—hematologic cancer	0.00791	0.0139	CbGbCtD
Propafenone—CYP2C9—Imatinib—hematologic cancer	0.00756	0.0133	CbGbCtD
Propafenone—ABCB1—Imatinib—hematologic cancer	0.00733	0.0129	CbGbCtD
Propafenone—CYP2D6—Imatinib—hematologic cancer	0.00691	0.0122	CbGbCtD
Propafenone—CYP2C9—Nilotinib—hematologic cancer	0.00687	0.0121	CbGbCtD
Propafenone—CYP1A2—Dasatinib—hematologic cancer	0.00674	0.0119	CbGbCtD
Propafenone—ABCB1—Nilotinib—hematologic cancer	0.00666	0.0117	CbGbCtD
Propafenone—ABCB1—Vinorelbine—hematologic cancer	0.00661	0.0116	CbGbCtD
Propafenone—CYP3A4—Methoxsalen—hematologic cancer	0.00631	0.0111	CbGbCtD
Propafenone—CYP2D6—Nilotinib—hematologic cancer	0.00628	0.0111	CbGbCtD
Propafenone—CYP2D6—Vinorelbine—hematologic cancer	0.00623	0.011	CbGbCtD
Propafenone—CYP3A4—Bortezomib—hematologic cancer	0.006	0.0106	CbGbCtD
Propafenone—ABCB1—Dasatinib—hematologic cancer	0.00589	0.0104	CbGbCtD
Propafenone—ABCB1—Mitoxantrone—hematologic cancer	0.00582	0.0103	CbGbCtD
Propafenone—CYP3A4—Daunorubicin—hematologic cancer	0.00574	0.0101	CbGbCtD
Propafenone—CYP2C8—Etoposide—hematologic cancer	0.00542	0.00955	CbGbCtD
Propafenone—ABCB1—Betamethasone—hematologic cancer	0.00519	0.00914	CbGbCtD
Propafenone—ABCB1—Gemcitabine—hematologic cancer	0.00514	0.00906	CbGbCtD
Propafenone—ABCB1—Prednisolone—hematologic cancer	0.00512	0.00902	CbGbCtD
Propafenone—CYP3A4—Cytarabine—hematologic cancer	0.00506	0.00892	CbGbCtD
Propafenone—CYP3A4—Teniposide—hematologic cancer	0.00498	0.00878	CbGbCtD
Propafenone—ABCB1—Prednisone—hematologic cancer	0.00483	0.00852	CbGbCtD
Propafenone—CYP3A4—Ifosfamide—hematologic cancer	0.0046	0.00811	CbGbCtD
Propafenone—ABCB1—Irinotecan—hematologic cancer	0.00458	0.00807	CbGbCtD
Propafenone—CYP2C8—Dexamethasone—hematologic cancer	0.00446	0.00785	CbGbCtD
Propafenone—CYP3A4—Imatinib—hematologic cancer	0.00439	0.00774	CbGbCtD
Propafenone—CYP1A2—Etoposide—hematologic cancer	0.0042	0.00739	CbGbCtD
Propafenone—CYP3A4—Ruxolitinib—hematologic cancer	0.00414	0.00729	CbGbCtD
Propafenone—ABCB1—Vinblastine—hematologic cancer	0.00407	0.00718	CbGbCtD
Propafenone—ABCB1—Vincristine—hematologic cancer	0.004	0.00706	CbGbCtD
Propafenone—CYP3A4—Nilotinib—hematologic cancer	0.00399	0.00704	CbGbCtD
Propafenone—CYP3A4—Vinorelbine—hematologic cancer	0.00396	0.00698	CbGbCtD
Propafenone—CYP2C9—Cisplatin—hematologic cancer	0.00385	0.00678	CbGbCtD
Propafenone—CYP2D6—Vinblastine—hematologic cancer	0.00384	0.00676	CbGbCtD
Propafenone—ABCB1—Cisplatin—hematologic cancer	0.00373	0.00658	CbGbCtD
Propafenone—ABCB1—Etoposide—hematologic cancer	0.00367	0.00647	CbGbCtD
Propafenone—CYP3A4—Triamcinolone—hematologic cancer	0.00362	0.00638	CbGbCtD
Propafenone—CYP3A4—Dasatinib—hematologic cancer	0.00353	0.00622	CbGbCtD
Propafenone—CYP3A4—Mitoxantrone—hematologic cancer	0.00349	0.00614	CbGbCtD
Propafenone—CYP2C9—Dexamethasone—hematologic cancer	0.00311	0.00548	CbGbCtD
Propafenone—CYP3A4—Betamethasone—hematologic cancer	0.00311	0.00548	CbGbCtD
Propafenone—CYP3A4—Prednisolone—hematologic cancer	0.00307	0.0054	CbGbCtD
Propafenone—ABCB1—Dexamethasone—hematologic cancer	0.00302	0.00532	CbGbCtD
Propafenone—CYP3A4—Prednisone—hematologic cancer	0.0029	0.0051	CbGbCtD
Propafenone—CYP2D6—Dexamethasone—hematologic cancer	0.00284	0.00501	CbGbCtD
Propafenone—CYP3A4—Irinotecan—hematologic cancer	0.00274	0.00484	CbGbCtD
Propafenone—ABCB1—Doxorubicin—hematologic cancer	0.0025	0.00441	CbGbCtD
Propafenone—CYP3A4—Vinblastine—hematologic cancer	0.00244	0.0043	CbGbCtD
Propafenone—ABCB1—Methotrexate—hematologic cancer	0.00242	0.00427	CbGbCtD
Propafenone—CYP3A4—Vincristine—hematologic cancer	0.0024	0.00423	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—hematologic cancer	0.00236	0.00416	CbGbCtD
Propafenone—CYP3A4—Etoposide—hematologic cancer	0.0022	0.00387	CbGbCtD
Propafenone—CYP3A4—Dexamethasone—hematologic cancer	0.00181	0.00318	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—hematologic cancer	0.0015	0.00264	CbGbCtD
Propafenone—Benazepril—MTHFR—hematologic cancer	0.000312	0.264	CrCbGaD
Propafenone—Carvedilol—VEGFA—hematologic cancer	0.000236	0.2	CrCbGaD
Propafenone—Phenoxybenzamine—SLC22A1—hematologic cancer	0.000161	0.136	CrCbGaD
Propafenone—Mirabegron—ALB—hematologic cancer	0.000158	0.134	CrCbGaD
Propafenone—Mirabegron—ABCB1—hematologic cancer	0.000151	0.128	CrCbGaD
Propafenone—Carvedilol—ABCB1—hematologic cancer	6.07e-05	0.0514	CrCbGaD
Propafenone—Fentanyl—ABCB1—hematologic cancer	5.52e-05	0.0468	CrCbGaD
Propafenone—SCN5A—blood—hematologic cancer	4.97e-05	0.0729	CbGeAlD
Propafenone—Propranolol—ABCB1—hematologic cancer	4.61e-05	0.0391	CrCbGaD
Propafenone—KCNH2—hematopoietic system—hematologic cancer	4.61e-05	0.0677	CbGeAlD
Propafenone—CYP2C8—hematopoietic system—hematologic cancer	4.22e-05	0.0619	CbGeAlD
Propafenone—CYP1A2—hematopoietic system—hematologic cancer	3.95e-05	0.0579	CbGeAlD
Propafenone—CYP2C9—hematopoietic system—hematologic cancer	3.75e-05	0.055	CbGeAlD
Propafenone—ADRB1—lung—hematologic cancer	3.51e-05	0.0515	CbGeAlD
Propafenone—KCNH2—blood—hematologic cancer	3.05e-05	0.0448	CbGeAlD
Propafenone—KCNH2—bone marrow—hematologic cancer	2.95e-05	0.0434	CbGeAlD
Propafenone—CYP3A4—hematopoietic system—hematologic cancer	2.86e-05	0.0419	CbGeAlD
Propafenone—CYP2D6—hematopoietic system—hematologic cancer	2.81e-05	0.0413	CbGeAlD
Propafenone—CYP2C8—blood—hematologic cancer	2.79e-05	0.041	CbGeAlD
Propafenone—CYP1A2—blood—hematologic cancer	2.61e-05	0.0384	CbGeAlD
Propafenone—KCNH2—testis—hematologic cancer	2.53e-05	0.0371	CbGeAlD
Propafenone—CYP2C9—blood—hematologic cancer	2.48e-05	0.0364	CbGeAlD
Propafenone—CYP2C8—testis—hematologic cancer	2.31e-05	0.0339	CbGeAlD
Propafenone—CYP1A2—lung—hematologic cancer	2.29e-05	0.0337	CbGeAlD
Propafenone—ABCB1—hematopoietic system—hematologic cancer	2.02e-05	0.0297	CbGeAlD
Propafenone—CYP3A4—blood—hematologic cancer	1.89e-05	0.0278	CbGeAlD
Propafenone—CYP2D6—blood—hematologic cancer	1.86e-05	0.0273	CbGeAlD
Propafenone—KCNH2—lymph node—hematologic cancer	1.83e-05	0.0269	CbGeAlD
Propafenone—Erythema—Epirubicin—hematologic cancer	1.56e-05	5.79e-05	CcSEcCtD
Propafenone—Diarrhoea—Etoposide—hematologic cancer	1.55e-05	5.77e-05	CcSEcCtD
Propafenone—Anorexia—Prednisone—hematologic cancer	1.55e-05	5.76e-05	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—hematologic cancer	1.54e-05	5.76e-05	CcSEcCtD
Propafenone—Ill-defined disorder—Methotrexate—hematologic cancer	1.54e-05	5.74e-05	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—hematologic cancer	1.54e-05	5.74e-05	CcSEcCtD
Propafenone—CYP2D6—testis—hematologic cancer	1.54e-05	0.0226	CbGeAlD
Propafenone—ABCB1—gonad—hematologic cancer	1.54e-05	0.0226	CbGeAlD
Propafenone—Anaemia—Methotrexate—hematologic cancer	1.54e-05	5.72e-05	CcSEcCtD
Propafenone—Feeling abnormal—Dexamethasone—hematologic cancer	1.54e-05	5.72e-05	CcSEcCtD
Propafenone—Feeling abnormal—Betamethasone—hematologic cancer	1.54e-05	5.72e-05	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—hematologic cancer	1.53e-05	5.72e-05	CcSEcCtD
Propafenone—Flushing—Doxorubicin—hematologic cancer	1.53e-05	5.72e-05	CcSEcCtD
Propafenone—Flatulence—Epirubicin—hematologic cancer	1.53e-05	5.71e-05	CcSEcCtD
Propafenone—Tension—Epirubicin—hematologic cancer	1.53e-05	5.69e-05	CcSEcCtD
Propafenone—Gastrointestinal pain—Betamethasone—hematologic cancer	1.52e-05	5.68e-05	CcSEcCtD
Propafenone—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.52e-05	5.68e-05	CcSEcCtD
Propafenone—Dysgeusia—Epirubicin—hematologic cancer	1.52e-05	5.67e-05	CcSEcCtD
Propafenone—Hypersensitivity—Triamcinolone—hematologic cancer	1.51e-05	5.64e-05	CcSEcCtD
Propafenone—Nervousness—Epirubicin—hematologic cancer	1.51e-05	5.63e-05	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—hematologic cancer	1.5e-05	5.59e-05	CcSEcCtD
Propafenone—Malaise—Methotrexate—hematologic cancer	1.5e-05	5.58e-05	CcSEcCtD
Propafenone—Dizziness—Etoposide—hematologic cancer	1.5e-05	5.58e-05	CcSEcCtD
Propafenone—Muscle spasms—Epirubicin—hematologic cancer	1.5e-05	5.57e-05	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—hematologic cancer	1.49e-05	5.56e-05	CcSEcCtD
Propafenone—Vertigo—Methotrexate—hematologic cancer	1.49e-05	5.56e-05	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—hematologic cancer	1.49e-05	5.55e-05	CcSEcCtD
Propafenone—Leukopenia—Methotrexate—hematologic cancer	1.49e-05	5.54e-05	CcSEcCtD
Propafenone—Urticaria—Betamethasone—hematologic cancer	1.48e-05	5.52e-05	CcSEcCtD
Propafenone—Urticaria—Dexamethasone—hematologic cancer	1.48e-05	5.52e-05	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.48e-05	5.51e-05	CcSEcCtD
Propafenone—Dizziness—Prednisolone—hematologic cancer	1.48e-05	5.5e-05	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—hematologic cancer	1.48e-05	5.5e-05	CcSEcCtD
Propafenone—Asthenia—Triamcinolone—hematologic cancer	1.47e-05	5.49e-05	CcSEcCtD
Propafenone—Body temperature increased—Betamethasone—hematologic cancer	1.47e-05	5.49e-05	CcSEcCtD
Propafenone—Abdominal pain—Betamethasone—hematologic cancer	1.47e-05	5.49e-05	CcSEcCtD
Propafenone—Body temperature increased—Dexamethasone—hematologic cancer	1.47e-05	5.49e-05	CcSEcCtD
Propafenone—Abdominal pain—Dexamethasone—hematologic cancer	1.47e-05	5.49e-05	CcSEcCtD
Propafenone—Nausea—Cisplatin—hematologic cancer	1.47e-05	5.47e-05	CcSEcCtD
Propafenone—Insomnia—Prednisone—hematologic cancer	1.47e-05	5.47e-05	CcSEcCtD
Propafenone—Vision blurred—Epirubicin—hematologic cancer	1.47e-05	5.46e-05	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—hematologic cancer	1.46e-05	5.44e-05	CcSEcCtD
Propafenone—Paraesthesia—Prednisone—hematologic cancer	1.46e-05	5.43e-05	CcSEcCtD
Propafenone—Pruritus—Triamcinolone—hematologic cancer	1.45e-05	5.41e-05	CcSEcCtD
Propafenone—Cough—Methotrexate—hematologic cancer	1.45e-05	5.4e-05	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—hematologic cancer	1.45e-05	5.4e-05	CcSEcCtD
Propafenone—Ill-defined disorder—Epirubicin—hematologic cancer	1.44e-05	5.38e-05	CcSEcCtD
Propafenone—Convulsion—Methotrexate—hematologic cancer	1.44e-05	5.36e-05	CcSEcCtD
Propafenone—Vomiting—Etoposide—hematologic cancer	1.44e-05	5.36e-05	CcSEcCtD
Propafenone—Erythema—Doxorubicin—hematologic cancer	1.44e-05	5.36e-05	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—hematologic cancer	1.44e-05	5.36e-05	CcSEcCtD
Propafenone—Anaemia—Epirubicin—hematologic cancer	1.44e-05	5.36e-05	CcSEcCtD
Propafenone—Dyspepsia—Prednisone—hematologic cancer	1.43e-05	5.32e-05	CcSEcCtD
Propafenone—Rash—Etoposide—hematologic cancer	1.43e-05	5.32e-05	CcSEcCtD
Propafenone—Dermatitis—Etoposide—hematologic cancer	1.43e-05	5.31e-05	CcSEcCtD
Propafenone—Headache—Etoposide—hematologic cancer	1.42e-05	5.28e-05	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—hematologic cancer	1.42e-05	5.28e-05	CcSEcCtD
Propafenone—Myalgia—Methotrexate—hematologic cancer	1.41e-05	5.27e-05	CcSEcCtD
Propafenone—Chest pain—Methotrexate—hematologic cancer	1.41e-05	5.27e-05	CcSEcCtD
Propafenone—Tension—Doxorubicin—hematologic cancer	1.41e-05	5.26e-05	CcSEcCtD
Propafenone—Decreased appetite—Prednisone—hematologic cancer	1.41e-05	5.26e-05	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—hematologic cancer	1.41e-05	5.25e-05	CcSEcCtD
Propafenone—Rash—Prednisolone—hematologic cancer	1.41e-05	5.25e-05	CcSEcCtD
Propafenone—Dermatitis—Prednisolone—hematologic cancer	1.41e-05	5.24e-05	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.41e-05	5.23e-05	CcSEcCtD
Propafenone—Malaise—Epirubicin—hematologic cancer	1.4e-05	5.22e-05	CcSEcCtD
Propafenone—Fatigue—Prednisone—hematologic cancer	1.4e-05	5.21e-05	CcSEcCtD
Propafenone—Headache—Prednisolone—hematologic cancer	1.4e-05	5.21e-05	CcSEcCtD
Propafenone—Discomfort—Methotrexate—hematologic cancer	1.4e-05	5.21e-05	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—hematologic cancer	1.4e-05	5.21e-05	CcSEcCtD
Propafenone—Vertigo—Epirubicin—hematologic cancer	1.4e-05	5.21e-05	CcSEcCtD
Propafenone—Syncope—Epirubicin—hematologic cancer	1.39e-05	5.2e-05	CcSEcCtD
Propafenone—Leukopenia—Epirubicin—hematologic cancer	1.39e-05	5.19e-05	CcSEcCtD
Propafenone—Constipation—Prednisone—hematologic cancer	1.39e-05	5.17e-05	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—hematologic cancer	1.38e-05	5.15e-05	CcSEcCtD
Propafenone—Palpitations—Epirubicin—hematologic cancer	1.37e-05	5.12e-05	CcSEcCtD
Propafenone—Confusional state—Methotrexate—hematologic cancer	1.37e-05	5.09e-05	CcSEcCtD
Propafenone—Loss of consciousness—Epirubicin—hematologic cancer	1.37e-05	5.09e-05	CcSEcCtD
Propafenone—Dizziness—Triamcinolone—hematologic cancer	1.36e-05	5.06e-05	CcSEcCtD
Propafenone—Cough—Epirubicin—hematologic cancer	1.36e-05	5.06e-05	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—hematologic cancer	1.36e-05	5.05e-05	CcSEcCtD
Propafenone—Convulsion—Epirubicin—hematologic cancer	1.35e-05	5.02e-05	CcSEcCtD
Propafenone—Infection—Methotrexate—hematologic cancer	1.35e-05	5.02e-05	CcSEcCtD
Propafenone—Nausea—Etoposide—hematologic cancer	1.35e-05	5.01e-05	CcSEcCtD
Propafenone—Hypertension—Epirubicin—hematologic cancer	1.34e-05	5e-05	CcSEcCtD
Propafenone—ABCB1—blood—hematologic cancer	1.34e-05	0.0197	CbGeAlD
Propafenone—Feeling abnormal—Prednisone—hematologic cancer	1.34e-05	4.98e-05	CcSEcCtD
Propafenone—Asthenia—Dexamethasone—hematologic cancer	1.34e-05	4.98e-05	CcSEcCtD
Propafenone—Asthenia—Betamethasone—hematologic cancer	1.34e-05	4.98e-05	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—hematologic cancer	1.34e-05	4.97e-05	CcSEcCtD
Propafenone—Nervous system disorder—Methotrexate—hematologic cancer	1.33e-05	4.96e-05	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—hematologic cancer	1.33e-05	4.95e-05	CcSEcCtD
Propafenone—Thrombocytopenia—Methotrexate—hematologic cancer	1.33e-05	4.95e-05	CcSEcCtD
Propafenone—Gastrointestinal pain—Prednisone—hematologic cancer	1.33e-05	4.94e-05	CcSEcCtD
Propafenone—Nausea—Prednisolone—hematologic cancer	1.33e-05	4.94e-05	CcSEcCtD
Propafenone—Myalgia—Epirubicin—hematologic cancer	1.32e-05	4.93e-05	CcSEcCtD
Propafenone—Chest pain—Epirubicin—hematologic cancer	1.32e-05	4.93e-05	CcSEcCtD
Propafenone—Anxiety—Epirubicin—hematologic cancer	1.32e-05	4.92e-05	CcSEcCtD
Propafenone—Pruritus—Dexamethasone—hematologic cancer	1.32e-05	4.91e-05	CcSEcCtD
Propafenone—Pruritus—Betamethasone—hematologic cancer	1.32e-05	4.91e-05	CcSEcCtD
Propafenone—Skin disorder—Methotrexate—hematologic cancer	1.32e-05	4.91e-05	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.31e-05	4.9e-05	CcSEcCtD
Propafenone—Hyperhidrosis—Methotrexate—hematologic cancer	1.31e-05	4.88e-05	CcSEcCtD
Propafenone—Discomfort—Epirubicin—hematologic cancer	1.31e-05	4.87e-05	CcSEcCtD
Propafenone—Vomiting—Triamcinolone—hematologic cancer	1.31e-05	4.86e-05	CcSEcCtD
Propafenone—Malaise—Doxorubicin—hematologic cancer	1.3e-05	4.83e-05	CcSEcCtD
Propafenone—ABCB1—bone marrow—hematologic cancer	1.3e-05	0.019	CbGeAlD
Propafenone—Rash—Triamcinolone—hematologic cancer	1.29e-05	4.82e-05	CcSEcCtD
Propafenone—Dry mouth—Epirubicin—hematologic cancer	1.29e-05	4.82e-05	CcSEcCtD
Propafenone—Dermatitis—Triamcinolone—hematologic cancer	1.29e-05	4.82e-05	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—hematologic cancer	1.29e-05	4.82e-05	CcSEcCtD
Propafenone—Anorexia—Methotrexate—hematologic cancer	1.29e-05	4.82e-05	CcSEcCtD
Propafenone—Syncope—Doxorubicin—hematologic cancer	1.29e-05	4.81e-05	CcSEcCtD
Propafenone—Urticaria—Prednisone—hematologic cancer	1.29e-05	4.8e-05	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—hematologic cancer	1.29e-05	4.8e-05	CcSEcCtD
Propafenone—Headache—Triamcinolone—hematologic cancer	1.29e-05	4.79e-05	CcSEcCtD
Propafenone—Abdominal pain—Prednisone—hematologic cancer	1.28e-05	4.78e-05	CcSEcCtD
Propafenone—Body temperature increased—Prednisone—hematologic cancer	1.28e-05	4.78e-05	CcSEcCtD
Propafenone—Confusional state—Epirubicin—hematologic cancer	1.28e-05	4.77e-05	CcSEcCtD
Propafenone—Diarrhoea—Dexamethasone—hematologic cancer	1.28e-05	4.75e-05	CcSEcCtD
Propafenone—Diarrhoea—Betamethasone—hematologic cancer	1.28e-05	4.75e-05	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—hematologic cancer	1.27e-05	4.74e-05	CcSEcCtD
Propafenone—Oedema—Epirubicin—hematologic cancer	1.27e-05	4.73e-05	CcSEcCtD
Propafenone—Hypotension—Methotrexate—hematologic cancer	1.27e-05	4.72e-05	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—hematologic cancer	1.26e-05	4.71e-05	CcSEcCtD
Propafenone—Infection—Epirubicin—hematologic cancer	1.26e-05	4.7e-05	CcSEcCtD
Propafenone—Cough—Doxorubicin—hematologic cancer	1.26e-05	4.68e-05	CcSEcCtD
Propafenone—Shock—Epirubicin—hematologic cancer	1.25e-05	4.65e-05	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—hematologic cancer	1.25e-05	4.64e-05	CcSEcCtD
Propafenone—Nervous system disorder—Epirubicin—hematologic cancer	1.24e-05	4.64e-05	CcSEcCtD
Propafenone—Thrombocytopenia—Epirubicin—hematologic cancer	1.24e-05	4.63e-05	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—hematologic cancer	1.24e-05	4.63e-05	CcSEcCtD
Propafenone—Tachycardia—Epirubicin—hematologic cancer	1.24e-05	4.61e-05	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.24e-05	4.6e-05	CcSEcCtD
Propafenone—Skin disorder—Epirubicin—hematologic cancer	1.23e-05	4.59e-05	CcSEcCtD
Propafenone—Dizziness—Dexamethasone—hematologic cancer	1.23e-05	4.59e-05	CcSEcCtD
Propafenone—Dizziness—Betamethasone—hematologic cancer	1.23e-05	4.59e-05	CcSEcCtD
Propafenone—Hyperhidrosis—Epirubicin—hematologic cancer	1.23e-05	4.57e-05	CcSEcCtD
Propafenone—Insomnia—Methotrexate—hematologic cancer	1.23e-05	4.57e-05	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—hematologic cancer	1.23e-05	4.56e-05	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—hematologic cancer	1.23e-05	4.56e-05	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—hematologic cancer	1.22e-05	4.55e-05	CcSEcCtD
Propafenone—Nausea—Triamcinolone—hematologic cancer	1.22e-05	4.54e-05	CcSEcCtD
Propafenone—Paraesthesia—Methotrexate—hematologic cancer	1.22e-05	4.54e-05	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.22e-05	4.53e-05	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—hematologic cancer	1.21e-05	4.51e-05	CcSEcCtD
Propafenone—Anorexia—Epirubicin—hematologic cancer	1.21e-05	4.51e-05	CcSEcCtD
Propafenone—Dyspnoea—Methotrexate—hematologic cancer	1.21e-05	4.5e-05	CcSEcCtD
Propafenone—Somnolence—Methotrexate—hematologic cancer	1.21e-05	4.49e-05	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—hematologic cancer	1.2e-05	4.46e-05	CcSEcCtD
Propafenone—Hypersensitivity—Prednisone—hematologic cancer	1.2e-05	4.45e-05	CcSEcCtD
Propafenone—Dyspepsia—Methotrexate—hematologic cancer	1.19e-05	4.45e-05	CcSEcCtD
Propafenone—Hypotension—Epirubicin—hematologic cancer	1.19e-05	4.42e-05	CcSEcCtD
Propafenone—Vomiting—Betamethasone—hematologic cancer	1.18e-05	4.41e-05	CcSEcCtD
Propafenone—Vomiting—Dexamethasone—hematologic cancer	1.18e-05	4.41e-05	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—hematologic cancer	1.18e-05	4.41e-05	CcSEcCtD
Propafenone—Decreased appetite—Methotrexate—hematologic cancer	1.18e-05	4.39e-05	CcSEcCtD
Propafenone—Rash—Betamethasone—hematologic cancer	1.18e-05	4.38e-05	CcSEcCtD
Propafenone—Rash—Dexamethasone—hematologic cancer	1.18e-05	4.38e-05	CcSEcCtD
Propafenone—Oedema—Doxorubicin—hematologic cancer	1.17e-05	4.38e-05	CcSEcCtD
Propafenone—ABCB1—lung—hematologic cancer	1.17e-05	0.0172	CbGeAlD
Propafenone—Dermatitis—Dexamethasone—hematologic cancer	1.17e-05	4.37e-05	CcSEcCtD
Propafenone—Dermatitis—Betamethasone—hematologic cancer	1.17e-05	4.37e-05	CcSEcCtD
Propafenone—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.17e-05	4.36e-05	CcSEcCtD
Propafenone—Fatigue—Methotrexate—hematologic cancer	1.17e-05	4.36e-05	CcSEcCtD
Propafenone—Headache—Dexamethasone—hematologic cancer	1.17e-05	4.35e-05	CcSEcCtD
Propafenone—Headache—Betamethasone—hematologic cancer	1.17e-05	4.35e-05	CcSEcCtD
Propafenone—Infection—Doxorubicin—hematologic cancer	1.17e-05	4.35e-05	CcSEcCtD
Propafenone—Asthenia—Prednisone—hematologic cancer	1.16e-05	4.34e-05	CcSEcCtD
Propafenone—Pain—Methotrexate—hematologic cancer	1.16e-05	4.32e-05	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.16e-05	4.31e-05	CcSEcCtD
Propafenone—Shock—Doxorubicin—hematologic cancer	1.16e-05	4.3e-05	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—hematologic cancer	1.15e-05	4.29e-05	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—hematologic cancer	1.15e-05	4.28e-05	CcSEcCtD
Propafenone—Pruritus—Prednisone—hematologic cancer	1.15e-05	4.28e-05	CcSEcCtD
Propafenone—Insomnia—Epirubicin—hematologic cancer	1.15e-05	4.28e-05	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—hematologic cancer	1.15e-05	4.27e-05	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—hematologic cancer	1.14e-05	4.25e-05	CcSEcCtD
Propafenone—Paraesthesia—Epirubicin—hematologic cancer	1.14e-05	4.25e-05	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—hematologic cancer	1.14e-05	4.23e-05	CcSEcCtD
Propafenone—Dyspnoea—Epirubicin—hematologic cancer	1.13e-05	4.22e-05	CcSEcCtD
Propafenone—Somnolence—Epirubicin—hematologic cancer	1.13e-05	4.2e-05	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—hematologic cancer	1.12e-05	4.17e-05	CcSEcCtD
Propafenone—Feeling abnormal—Methotrexate—hematologic cancer	1.12e-05	4.16e-05	CcSEcCtD
Propafenone—Dyspepsia—Epirubicin—hematologic cancer	1.12e-05	4.16e-05	CcSEcCtD
Propafenone—Diarrhoea—Prednisone—hematologic cancer	1.11e-05	4.14e-05	CcSEcCtD
Propafenone—Gastrointestinal pain—Methotrexate—hematologic cancer	1.11e-05	4.13e-05	CcSEcCtD
Propafenone—ABCB1—testis—hematologic cancer	1.11e-05	0.0163	CbGeAlD
Propafenone—Nausea—Dexamethasone—hematologic cancer	1.11e-05	4.12e-05	CcSEcCtD
Propafenone—Nausea—Betamethasone—hematologic cancer	1.11e-05	4.12e-05	CcSEcCtD
Propafenone—Decreased appetite—Epirubicin—hematologic cancer	1.1e-05	4.11e-05	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—hematologic cancer	1.1e-05	4.09e-05	CcSEcCtD
Propafenone—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.1e-05	4.08e-05	CcSEcCtD
Propafenone—Fatigue—Epirubicin—hematologic cancer	1.09e-05	4.08e-05	CcSEcCtD
Propafenone—Pain—Epirubicin—hematologic cancer	1.09e-05	4.04e-05	CcSEcCtD
Propafenone—Constipation—Epirubicin—hematologic cancer	1.09e-05	4.04e-05	CcSEcCtD
Propafenone—Urticaria—Methotrexate—hematologic cancer	1.08e-05	4.01e-05	CcSEcCtD
Propafenone—Dizziness—Prednisone—hematologic cancer	1.07e-05	4e-05	CcSEcCtD
Propafenone—Abdominal pain—Methotrexate—hematologic cancer	1.07e-05	3.99e-05	CcSEcCtD
Propafenone—Body temperature increased—Methotrexate—hematologic cancer	1.07e-05	3.99e-05	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.07e-05	3.99e-05	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—hematologic cancer	1.06e-05	3.96e-05	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—hematologic cancer	1.05e-05	3.93e-05	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—hematologic cancer	1.05e-05	3.9e-05	CcSEcCtD
Propafenone—Feeling abnormal—Epirubicin—hematologic cancer	1.05e-05	3.9e-05	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—hematologic cancer	1.04e-05	3.89e-05	CcSEcCtD
Propafenone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.04e-05	3.87e-05	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—hematologic cancer	1.03e-05	3.85e-05	CcSEcCtD
Propafenone—Vomiting—Prednisone—hematologic cancer	1.03e-05	3.84e-05	CcSEcCtD
Propafenone—Rash—Prednisone—hematologic cancer	1.02e-05	3.81e-05	CcSEcCtD
Propafenone—Dermatitis—Prednisone—hematologic cancer	1.02e-05	3.81e-05	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—hematologic cancer	1.02e-05	3.8e-05	CcSEcCtD
Propafenone—Headache—Prednisone—hematologic cancer	1.02e-05	3.79e-05	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.01e-05	3.78e-05	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—hematologic cancer	1.01e-05	3.77e-05	CcSEcCtD
Propafenone—Urticaria—Epirubicin—hematologic cancer	1.01e-05	3.76e-05	CcSEcCtD
Propafenone—Pain—Doxorubicin—hematologic cancer	1e-05	3.74e-05	CcSEcCtD
Propafenone—Constipation—Doxorubicin—hematologic cancer	1e-05	3.74e-05	CcSEcCtD
Propafenone—Abdominal pain—Epirubicin—hematologic cancer	1e-05	3.74e-05	CcSEcCtD
Propafenone—Body temperature increased—Epirubicin—hematologic cancer	1e-05	3.74e-05	CcSEcCtD
Propafenone—Hypersensitivity—Methotrexate—hematologic cancer	9.99e-06	3.72e-05	CcSEcCtD
Propafenone—Asthenia—Methotrexate—hematologic cancer	9.73e-06	3.63e-05	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—hematologic cancer	9.68e-06	3.61e-05	CcSEcCtD
Propafenone—Nausea—Prednisone—hematologic cancer	9.64e-06	3.59e-05	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.6e-06	3.58e-05	CcSEcCtD
Propafenone—Pruritus—Methotrexate—hematologic cancer	9.6e-06	3.57e-05	CcSEcCtD
Propafenone—Hypersensitivity—Epirubicin—hematologic cancer	9.35e-06	3.48e-05	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—hematologic cancer	9.33e-06	3.48e-05	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—hematologic cancer	9.28e-06	3.46e-05	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—hematologic cancer	9.28e-06	3.46e-05	CcSEcCtD
Propafenone—Diarrhoea—Methotrexate—hematologic cancer	9.28e-06	3.46e-05	CcSEcCtD
Propafenone—Asthenia—Epirubicin—hematologic cancer	9.11e-06	3.39e-05	CcSEcCtD
Propafenone—Pruritus—Epirubicin—hematologic cancer	8.98e-06	3.35e-05	CcSEcCtD
Propafenone—Dizziness—Methotrexate—hematologic cancer	8.97e-06	3.34e-05	CcSEcCtD
Propafenone—Diarrhoea—Epirubicin—hematologic cancer	8.68e-06	3.24e-05	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—hematologic cancer	8.65e-06	3.22e-05	CcSEcCtD
Propafenone—Vomiting—Methotrexate—hematologic cancer	8.62e-06	3.21e-05	CcSEcCtD
Propafenone—Rash—Methotrexate—hematologic cancer	8.55e-06	3.19e-05	CcSEcCtD
Propafenone—Dermatitis—Methotrexate—hematologic cancer	8.54e-06	3.18e-05	CcSEcCtD
Propafenone—Headache—Methotrexate—hematologic cancer	8.5e-06	3.17e-05	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—hematologic cancer	8.43e-06	3.14e-05	CcSEcCtD
Propafenone—Dizziness—Epirubicin—hematologic cancer	8.39e-06	3.13e-05	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—hematologic cancer	8.31e-06	3.1e-05	CcSEcCtD
Propafenone—Vomiting—Epirubicin—hematologic cancer	8.07e-06	3.01e-05	CcSEcCtD
Propafenone—Nausea—Methotrexate—hematologic cancer	8.06e-06	3e-05	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—hematologic cancer	8.04e-06	2.99e-05	CcSEcCtD
Propafenone—ABCB1—lymph node—hematologic cancer	8.03e-06	0.0118	CbGeAlD
Propafenone—Rash—Epirubicin—hematologic cancer	8e-06	2.98e-05	CcSEcCtD
Propafenone—Dermatitis—Epirubicin—hematologic cancer	8e-06	2.98e-05	CcSEcCtD
Propafenone—Headache—Epirubicin—hematologic cancer	7.95e-06	2.96e-05	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—hematologic cancer	7.77e-06	2.89e-05	CcSEcCtD
Propafenone—Nausea—Epirubicin—hematologic cancer	7.54e-06	2.81e-05	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—hematologic cancer	7.47e-06	2.78e-05	CcSEcCtD
Propafenone—Rash—Doxorubicin—hematologic cancer	7.41e-06	2.76e-05	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—hematologic cancer	7.4e-06	2.76e-05	CcSEcCtD
Propafenone—Headache—Doxorubicin—hematologic cancer	7.36e-06	2.74e-05	CcSEcCtD
Propafenone—Nausea—Doxorubicin—hematologic cancer	6.98e-06	2.6e-05	CcSEcCtD
Propafenone—CYP2D6—Metabolism—ABCG2—hematologic cancer	5.6e-06	8.68e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTR—hematologic cancer	5.6e-06	8.68e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	5.58e-06	8.64e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AGRN—hematologic cancer	5.57e-06	8.63e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.55e-06	8.6e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTR—hematologic cancer	5.55e-06	8.6e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	5.55e-06	8.59e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	5.53e-06	8.56e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—JAK1—hematologic cancer	5.53e-06	8.56e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SDC1—hematologic cancer	5.53e-06	8.56e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ENO2—hematologic cancer	5.49e-06	8.51e-05	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.49e-06	8.5e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—UGT1A1—hematologic cancer	5.47e-06	8.48e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ENO2—hematologic cancer	5.44e-06	8.43e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CD44—hematologic cancer	5.39e-06	8.35e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NQO1—hematologic cancer	5.39e-06	8.35e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTT1—hematologic cancer	5.33e-06	8.25e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.32e-06	8.25e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.32e-06	8.25e-05	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.29e-06	8.2e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMMR—hematologic cancer	5.28e-06	8.18e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—IDH2—hematologic cancer	5.28e-06	8.18e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.28e-06	8.18e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.28e-06	8.18e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SDC1—hematologic cancer	5.21e-06	8.07e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.2e-06	8.06e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.19e-06	8.04e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	5.16e-06	8e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SDC1—hematologic cancer	5.16e-06	8e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL2—hematologic cancer	5.12e-06	7.94e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TERT—hematologic cancer	5.1e-06	7.91e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYCS—hematologic cancer	5.1e-06	7.9e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.07e-06	7.85e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NUP98—hematologic cancer	5.02e-06	7.78e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	4.98e-06	7.72e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.97e-06	7.69e-05	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.95e-06	7.67e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.93e-06	7.64e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.88e-06	7.56e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.88e-06	7.56e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TSC2—hematologic cancer	4.87e-06	7.54e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.87e-06	7.54e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NUP214—hematologic cancer	4.84e-06	7.5e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CA9—hematologic cancer	4.83e-06	7.48e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ACP5—hematologic cancer	4.83e-06	7.48e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.79e-06	7.42e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.77e-06	7.39e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTR—hematologic cancer	4.74e-06	7.35e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.74e-06	7.35e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CD44—hematologic cancer	4.7e-06	7.28e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NQO1—hematologic cancer	4.7e-06	7.28e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	4.68e-06	7.26e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.66e-06	7.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ENO2—hematologic cancer	4.65e-06	7.21e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	4.64e-06	7.18e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.56e-06	7.07e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ESR1—hematologic cancer	4.55e-06	7.05e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—IDH1—hematologic cancer	4.54e-06	7.04e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.51e-06	6.99e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.5e-06	6.97e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FN1—hematologic cancer	4.49e-06	6.96e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TXN—hematologic cancer	4.49e-06	6.96e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.49e-06	6.96e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.49e-06	6.96e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYCS—hematologic cancer	4.45e-06	6.89e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.44e-06	6.88e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	4.44e-06	6.88e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—BAD—hematologic cancer	4.44e-06	6.88e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CD44—hematologic cancer	4.43e-06	6.86e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NQO1—hematologic cancer	4.43e-06	6.86e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.42e-06	6.84e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SDC1—hematologic cancer	4.41e-06	6.83e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	4.4e-06	6.81e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.4e-06	6.81e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CD44—hematologic cancer	4.39e-06	6.8e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NQO1—hematologic cancer	4.39e-06	6.8e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.35e-06	6.74e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CD80—hematologic cancer	4.31e-06	6.67e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KIT—hematologic cancer	4.3e-06	6.66e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	4.3e-06	6.66e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	4.3e-06	6.66e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.3e-06	6.66e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.26e-06	6.6e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	4.23e-06	6.55e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.22e-06	6.54e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.21e-06	6.53e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYCS—hematologic cancer	4.19e-06	6.49e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.16e-06	6.45e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.16e-06	6.44e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYCS—hematologic cancer	4.15e-06	6.43e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.13e-06	6.4e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.13e-06	6.4e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.13e-06	6.39e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	4.12e-06	6.38e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.11e-06	6.36e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.11e-06	6.36e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CREB1—hematologic cancer	4.09e-06	6.34e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—BRAF—hematologic cancer	4.04e-06	6.26e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCL2—hematologic cancer	4.01e-06	6.2e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALOX5—hematologic cancer	4e-06	6.2e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6R—hematologic cancer	3.99e-06	6.19e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	3.99e-06	6.18e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.98e-06	6.16e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTP1—hematologic cancer	3.92e-06	6.07e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NUP98—hematologic cancer	3.88e-06	6.01e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	3.81e-06	5.9e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	3.78e-06	5.86e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.76e-06	5.83e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.76e-06	5.83e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CD44—hematologic cancer	3.75e-06	5.81e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NQO1—hematologic cancer	3.75e-06	5.81e-05	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.74e-06	5.8e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NUP214—hematologic cancer	3.74e-06	5.79e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.71e-06	5.75e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	3.7e-06	5.73e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.69e-06	5.72e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.67e-06	5.69e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTR—hematologic cancer	3.66e-06	5.67e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.66e-06	5.67e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.66e-06	5.67e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.65e-06	5.66e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGF2—hematologic cancer	3.62e-06	5.61e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NCOR1—hematologic cancer	3.6e-06	5.58e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—hematologic cancer	3.6e-06	5.58e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ENO2—hematologic cancer	3.59e-06	5.56e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	3.57e-06	5.53e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYCS—hematologic cancer	3.55e-06	5.5e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.54e-06	5.49e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.53e-06	5.46e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.5e-06	5.41e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.48e-06	5.4e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—JAK2—hematologic cancer	3.47e-06	5.38e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.46e-06	5.37e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SDC1—hematologic cancer	3.4e-06	5.27e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	3.4e-06	5.27e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.39e-06	5.26e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.39e-06	5.26e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MDM2—hematologic cancer	3.39e-06	5.25e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.36e-06	5.21e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.36e-06	5.21e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	3.3e-06	5.1e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MTOR—hematologic cancer	3.3e-06	5.1e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.22e-06	4.99e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—hematologic cancer	3.18e-06	4.93e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.17e-06	4.92e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	3.15e-06	4.87e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.13e-06	4.85e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	3.09e-06	4.79e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.07e-06	4.75e-05	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	3.06e-06	4.74e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CASP3—hematologic cancer	3.03e-06	4.7e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.03e-06	4.69e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2—hematologic cancer	3.03e-06	4.69e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—hematologic cancer	3.01e-06	4.66e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—hematologic cancer	3e-06	4.65e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.97e-06	4.61e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.96e-06	4.59e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—hematologic cancer	2.95e-06	4.57e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—JUN—hematologic cancer	2.94e-06	4.56e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NQO1—hematologic cancer	2.89e-06	4.48e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CD44—hematologic cancer	2.89e-06	4.48e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.87e-06	4.45e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.87e-06	4.45e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	2.85e-06	4.42e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTEN—hematologic cancer	2.85e-06	4.41e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.85e-06	4.41e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	2.79e-06	4.32e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	2.78e-06	4.3e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYCS—hematologic cancer	2.74e-06	4.24e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.72e-06	4.22e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EP300—hematologic cancer	2.72e-06	4.21e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.7e-06	4.18e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.67e-06	4.14e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALB—hematologic cancer	2.66e-06	4.13e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SRC—hematologic cancer	2.64e-06	4.09e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.62e-06	4.06e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	2.57e-06	3.98e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.55e-06	3.95e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STAT3—hematologic cancer	2.55e-06	3.95e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NRAS—hematologic cancer	2.54e-06	3.94e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.54e-06	3.94e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.52e-06	3.9e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.5e-06	3.87e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CREBBP—hematologic cancer	2.48e-06	3.84e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	2.43e-06	3.77e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.41e-06	3.74e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—hematologic cancer	2.37e-06	3.67e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	2.36e-06	3.66e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.35e-06	3.64e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.35e-06	3.64e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.34e-06	3.62e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALB—hematologic cancer	2.32e-06	3.59e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.32e-06	3.59e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.29e-06	3.54e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.24e-06	3.47e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.22e-06	3.44e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.22e-06	3.44e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.22e-06	3.44e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.21e-06	3.43e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.2e-06	3.4e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KRAS—hematologic cancer	2.19e-06	3.39e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALB—hematologic cancer	2.19e-06	3.39e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALB—hematologic cancer	2.17e-06	3.36e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.13e-06	3.31e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.09e-06	3.24e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.07e-06	3.21e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.05e-06	3.17e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTEN—hematologic cancer	2.03e-06	3.15e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	2.01e-06	3.11e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.98e-06	3.07e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.96e-06	3.04e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—hematologic cancer	1.94e-06	3.01e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—EP300—hematologic cancer	1.94e-06	3e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.93e-06	2.99e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.91e-06	2.96e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.88e-06	2.91e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HRAS—hematologic cancer	1.86e-06	2.88e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALB—hematologic cancer	1.85e-06	2.87e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—hematologic cancer	1.78e-06	2.76e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.77e-06	2.74e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTEN—hematologic cancer	1.77e-06	2.74e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—EP300—hematologic cancer	1.69e-06	2.62e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.67e-06	2.58e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTEN—hematologic cancer	1.65e-06	2.56e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.65e-06	2.55e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT1—hematologic cancer	1.64e-06	2.54e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.64e-06	2.53e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—EP300—hematologic cancer	1.59e-06	2.46e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—EP300—hematologic cancer	1.58e-06	2.44e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.53e-06	2.37e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.45e-06	2.24e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.43e-06	2.22e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALB—hematologic cancer	1.43e-06	2.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTEN—hematologic cancer	1.41e-06	2.19e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.37e-06	2.12e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—EP300—hematologic cancer	1.35e-06	2.09e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.26e-06	1.96e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.25e-06	1.93e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.18e-06	1.82e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKT1—hematologic cancer	1.17e-06	1.81e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.17e-06	1.81e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.09e-06	1.69e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—EP300—hematologic cancer	1.04e-06	1.61e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKT1—hematologic cancer	1.02e-06	1.58e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CA—hematologic cancer	9.97e-07	1.54e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKT1—hematologic cancer	9.61e-07	1.49e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKT1—hematologic cancer	9.53e-07	1.48e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKT1—hematologic cancer	8.14e-07	1.26e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.69e-07	1.19e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKT1—hematologic cancer	6.29e-07	9.74e-06	CbGpPWpGaD
